PyInvesting

Market research

688278.SHG Xiamen Amoytop Biotech Co., Ltd

SHG CNY Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
21B
P/E ratio
19.99
Analyst target
80
Dividend yield
1.0%
Beta
-0.17

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Xiamen Amoytop Biotech Co., Ltd is currently in a long term uptrend where the price is trading 0.7% above its 200 day moving average.

From a valuation standpoint, the stock is 76.5% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 17.0.

Based on the above factors, Xiamen Amoytop Biotech Co., Ltd gets an overall score of 1/5.